Results 331 to 340 of about 321,114 (362)
Some of the next articles are maybe not open access.

Oculopharyngeal muscular dystrophy: the muscular dystrophies

2001
Abstract Sweden, Switzerland, Czech Republic, Taiwan, United Kingdom, United States, Uzbekistan, Uruguay and Yugoslavia. However, OPMD is particularly prevalent in the French–Canadian population (1 1000) and in Bukhara Jews living in Israel (1: 600) (Blumen et al. 1997; Brais et al. 1995).
Bernard Brais, Fernando M S Tomè
openaire   +1 more source

Duchenne muscular dystrophy

Current Opinion in Genetics & Development, 1991
Progress in understanding the role of dystrophin raises promising hopes for a treatment for Duchenne muscular dystrophy. In addition, great improvements have been made in the ability to diagnose this disease using simple molecular methods.
J. Wicki, J.T. Seto, J.S. Chamberlain
openaire   +3 more sources

PHOSPHODIESTERS IN MUSCULAR DYSTROPHIES

Annals of the New York Academy of Sciences, 1979
Phosphorus nuclear magnetic resonance studies of various normal and dystrophic muscles have demonstrated differences in phosphodiester contents. Dystrophic chicken pectoralis muscle contains elevated levels of the diester SEP, and Duchenne dystrophic human leg muscle lacks the diester GPC. It is shown that SEP may be characteristic of slow fiber types,
Thomas Glonek   +4 more
openaire   +3 more sources

Duchenne muscular dystrophy

Neurology India, 2008
AbstractDuchenne muscular dystrophy, an X‐linked disorder, has an incidence of one in 5000 boys and presents in early childhood with proximal muscle weakness. Untreated boys become wheelchair bound by the age of 12 years and die of cardiorespiratory complications in their late teens to early 20s.
Eppie M. Yiu   +2 more
openaire   +5 more sources

Muscular Dystrophy

2013
Duchenne muscular dystrophy (DMD) is a complex disease characterized by multiple physiologic perturbations, progressively leading to cardiomyopathy, respiratory failure, and, eventually, death. Patients with DMD create unique challenges for the anesthesia team, including management of a difficult airway, avoidance of volatile anesthetics and ...
Renee Nierman Kreeger, James P Spaeth
openaire   +1 more source

Facioscapulohumeral muscular dystrophy

Current Opinion in Neurology, 2009
Knowledge of the pathogenetic mechanisms in facioscapulohumeral muscular dystrophy is still scattered, but has recently been advanced through novel developments on the genetic scientific front.The present brief review highlights some recent studies on the pathogenesis of facioscapulohumeral muscular dystrophy pointing to major involvement of muscle ...
Padberg, G.W.A.M., Engelen, B.G.M. van
openaire   +3 more sources

Oculopharyngeal Muscular Dystrophy

Seminars in Neurology, 1999
Autosomal dominant oculopharyngeal muscular dystrophy (OPMD) is an adult-onset disease with worldwide distribution. It usually presents in the fifth or sixth decades with progressive dysphagia, eyelid ptosis, and proximal limb weakness. Unique intranuclear filament inclusions in skeletal muscle fibers are its morphological hallmark. Surgical correction
M. Fardeau   +4 more
openaire   +3 more sources

Muscular dystrophy

2010
Abstracts and keywords to be supplied.
openaire   +1 more source

Duchenne muscular dystrophy

1995
Duchenne and Becker muscular dystrophy are X-linked muscle-wasting disorders that arise from mutations in the gene coding for dystrophin. The incidence of Duchenne muscular dystrophy (DMD) is approximately 1 in 3500 live male births, one-third of which are sporadic with no previous family history. In the absence of dystrophin, patients with DMD exhibit
Susan C. Brown, George Dickson
openaire   +3 more sources

Update on Muscular Dystrophies with Focus on Novel Treatments and Biomarkers

Current Neurology and Neuroscience Reports, 2020
N. Datta, P. Ghosh
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy